74%
jaeinvestorite kontodest jääb selle teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse.
Investeerimisega kaasnevad riskid ja need ei ole sobilikud kõigile investoritele. CFD-d on keerukad instrumendid, millega kaasneb võimenduse tõttu suur risk kaotada raha kiiresti.
74%
jaeinvestorite kontodest jääb selle teenusepakkuja juures CFD-dega kauplemisel kahjumisse.
Palume teil kaaluda, kas CFD-de toimimine on teile arusaadav ja kas te olete valmis võtma riski, mis suure tõenäosusega on kahjumlik.
74%
jaeinvestorite kontodest jääb selle teenusepakkuja juures hinnavahelepingutega kauplemisel kahjumisse.
Investeerimisega kaasnevad riskid ja need ei ole sobilikud kõigile investoritele. CFD-d on keerukad instrumendid, millega kaasneb võimenduse tõttu suur risk kaotada raha kiiresti.
74%
jaeinvestorite kontodest jääb selle teenusepakkuja juures CFD-dega kauplemisel kahjumisse.
Palume teil kaaluda, kas CFD-de toimimine on teile arusaadav ja kas te olete valmis võtma riski, mis suure tõenäosusega on kahjumlik.
Ackermans & van Haaren NV
Avatud
SektorRahandus
225.4 1.81
Ülevaade
Aktsiahinna muutus
24h
Min
221.2
Max
225
Sissetulek | 259M |
|---|---|
Müük | 3.2B |
P/E Sektori keskmine | 15.359 25.056 |
Aktsiakasum | 7.93 |
Dividenditootlus | 1.79 |
Kasumimarginaal | 8.217 |
Töötajad | 24,384 |
EBITDA | 601M |
Soovitused | Osta |
|---|---|
12 kuu keskmine prognoos | +17.31% upside |
Dividenditootlus Sektori keskmine | 1.79% 3.86% |
|---|---|
Järgmine tulemuste avaldamine | 29. aug 2025 |
Turukapital | 912M 7B |
|---|---|
Eelmine avamishind | 223.59 |
Eelmine sulgemishind | 225.4 |
Uudiste sentiment
By Acuity
34%
66%
123 / 535 Pingereas Finance
Ackermans & van Haaren NV Graafik
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
Seotud uudised
Võrdlus sarnastega
Hinnamuutus
Ackermans & van Haaren NV Prognoos
Hinnasiht
By TipRanks
17.31% tõus
12 kuu keskmine prognoos
Keskmine 185 EUR 17.31%
Kõrge 185 EUR
Madal 185 EUR
Põhineb 1 Wall Streeti analüütiku instrumendi Ackermans & van Haaren NV 12 kuu hinnasihil - viimase 3 kuu andmed.
Sentiment
By Acuity
123 / 535 Pingereas Rahandus
Uudiste sentiment
Languse märgid
Volatiilsus
Alla keskmise
Uudismaht (RCV)
Alla keskmise
Finantsandmed
Müügi- ja halduskulud
Tegevuskulud
Maksueelne kasum
Müük
Müügikulu
Brutokasum müügist
Intressikulud võla pealt
EBITDA
Ärikasum
$
Ettevõttest Ackermans & van Haaren NV
Ackermans & Van Haaren NV engages in marine engineering and contracting, private banking, real estate and senior care, and energy and resources businesses worldwide. The Marine Engineering & Contracting segment engages in the marine construction activities, including dredging and civil works on water, as well as offshore activities in the areas of renewable energy, oil and gas, soil and sludge remediation, and aggregate and mineral extraction; real estate development, multitechnics, and construction and renovation activities; and development of port projects and related industrial zones, as well as offshore wind farms. The Private Banking segment offers discretionary asset management services for private clients; specialized advisory banking services for entrepreneurs and liberal professionals; and financing and financial leasing of cars, equipment, charging stations, and bicycles. The Real Estate & Senior Care segment develops mixed real estate projects, including redevelopment of iconic buildings and new constructions; and develops residential, and retail and office properties. The Energy & Resources segment produces crude palm oil and bananas; offers hybrid palm oil seeds; and manufactures cement. The AvH & Growth Capital provides engineering and solutions in production process automation; validation and compliance services; production and sale of compact biogas installations; manufactures and supplies specialty chemicals; provides broadcast and media solutions; online and printed news; logistics for rail and road transport, and intermodal transport, and warehousing services; develops new vaccines, and crop and food protection products; and deals and leases commercial vehicles, and distribution of aftermarket products. This segment also develops medical devices; medicines for the treatment of cancer and genetic diseases; and supplies medical equipment and consumables to hospitals through online. The company was founded in 1876 and is based in Antwerp, Belgium.
